BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5582557)

  • 1. [Supplement to earlier published findings on the action mechanism of n-cyclohexyl-n-methyl(2-amino-3,5-dibrombenzyl)-ammonium chloride].
    Bürgi H; Regli J
    Ther Umsch; 1967 Mar; 24(3):116-8. PubMed ID: 5582557
    [No Abstract]   [Full Text] [Related]  

  • 2. [The identification of serum proteins in tracheobronchial secretion and their response to N-acyclohezyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium chloride].
    Maurer H
    Dtsch Med J; 1968 Sep; 19(18):634-6. PubMed ID: 5725485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of iodine in bronchial secretion during treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium-chloride].
    Baldamus U; Gries G
    Arzneimittelforschung; 1967 Jul; 17(7):870-1. PubMed ID: 5632847
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience with the use of a new mucolytic agent in therapy of respiratory insufficiency].
    Greco R; Prosperi A; Signore L
    Acta Anaesthesiol; 1970; 21(2):255-75. PubMed ID: 5536302
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with N-cyclohexyl-N-methyl(2-amino-3, 5-dibrombenzyl)-ammonium chloride (Bisolvon) in cytological examinations of the sputum].
    Harada K; Kondo T
    Gan No Rinsho; 1968 May; 14(5):434-7. PubMed ID: 5693801
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of Na 274 in 60 decompensated and ventilated patients with chronic respiratory insufficiency].
    Bolot JF; Gille Y; Bertoye A
    Lyon Med; 1971 Oct; 226(15):349-50. PubMed ID: 5288192
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electron microscopic studies of the effect of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on the bronchial epithelium of the rat].
    Merker HJ
    Arzneimittelforschung; 1966 Apr; 16(4):509-16. PubMed ID: 6014262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations on the effects of the association of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline in acute and chronic bronchopathies].
    Bini P; Romagnoli E
    Clin Ter; 1970 Dec; 55(5):433-59. PubMed ID: 5516108
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the action mechanism of the bronchosecretolytic N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride].
    Eigelsreiter H; Mair M
    Arzneimittelforschung; 1967 Mar; 17(3):353-5. PubMed ID: 4384866
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies].
    Carnimeo N; Fino E; Maiorano V; Marzullo F
    Minerva Med; 1969 Sep; 60(76):3557-64. PubMed ID: 5823750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bronchial syndromes treated with a combination of a secretolytic and oxytetracycline].
    Lolli N
    Clin Ter; 1970 Aug; 54(4):305-12. PubMed ID: 5490683
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electron microscopic studies of the effect of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium chloride on acid phosphatase of alveolar niche cells, bronchial goblet cells and neutrophilic leukocytes in rats].
    Spors S
    Arzneimittelforschung; 1970 Aug; 20(8):1091-3. PubMed ID: 5536509
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological effects of N-cyclohexyl-N-methyl-(2-amino-3, 5-dibrombenzyl)-ammonium chloride (Bisolvon) with special reference to its expectorant action.
    Shimamoto K; Honjo T
    Acta Sch Med Univ Kioto; 1967 Jul; 40(1):98-118. PubMed ID: 5591497
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic obstructive bronchopneumopathies with a combination of N-cycloesyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline].
    Freschi P; Galleazzi G; Narduzzo G
    Clin Ter; 1970 Nov; 55(4):345-51. PubMed ID: 5516891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical notes on the association of a mucolytic drug and a broad-spectrum antibiotic in the therapy of the bronchitic syndrome].
    Greco R; Pietropaoli P; Boccaletti E
    Acta Anaesthesiol; 1971; 22(1):109-23. PubMed ID: 5109623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and clinico-experimental studies on the evaluation of the broncho-secretory agent N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium chloride].
    ARCH F
    Arzneimittelforschung; 1963 Jun; 13():480-5. PubMed ID: 14013606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic bronchopulmonary diseases with a N-(2-amino-3,5-dibromobenzyl-N-methyl-N-cyclohexl-ammonium chloride and benzidamine chlorohydrate combination].
    Gini R
    Prensa Med Argent; 1971; 58(13):673-6. PubMed ID: 5566940
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a new respiratory analeptic, piperidino-methyl-cyclohexane (camphosulfonate) (S.D. 210.37) in ventilatory insufficiency and as a recovery agent in anesthesiology].
    Boissier JR; Valletta J; Bretagne M
    Cah Anesthesiol; 1968; 16(1):75-83. PubMed ID: 4392465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results with the combination of erythromycin-bromhexine in respiratory tract diseases in children].
    Kerschensteiner E
    Med Monatsschr; 1972 Sep; 26(9):426-8. PubMed ID: 5082178
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results obtained with a drug combination used in chronic bronchopulmonary diseases].
    Vives CF; Pastor CA
    Prensa Med Argent; 1972 May; 59(14):552-7. PubMed ID: 5042135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.